Advanced search
Publication Cover
Risk Management and Healthcare Policy Volume 3, 2010 - Issue
Submit an article Journal homepage
58
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Characterization and evaluation of the directly observed treatment for tuberculosis in Santiago de Compostela (1996–2006)

Beatriz Mejuto1 Pharmacology Department, Faculty of Pharmacy, University of Santiago de Compostela, Santiago de Compostela, SpainCorrespondence[email protected]
,
Victoria Tuñez2 Tuberculosis Unit, Preventive Medicine Department, Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
,
María Luisa Pérez del Molino3 Microbiology Department, Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
&
Rosario García4 Pharmacy Department, Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
Pages 21-26 | Published online: 22 Jun 2010

References

  • Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2008.393Geneva, SwitzerlandWorld Health Organization2008
  • CroftonJChauletPMaherDGuidelines for the management of drug-resistant tuberculosis. WHO/TB/96210 (Rev1)Geneva, SwitzerlandWorld Health Organization1997
  • AaronLSaadounDCalatroniITuberculosis in HIV-infected patients: a comprehensive reviewClini Microbiol Infect20041388398
  • Ministerio de Sanidad y ConsumoPlan para la prevención y control de la tuberculosis en EspanaDocumento aprobado por la Comisión de Salud Pública del Consejo Interterritorial del Sistema Nacional de Salud el 15 de Noviembre de 2007 y por el Consejo Interterritorial del Sistema Nacional de Salud el 18 de Junio de 2008Madrid2008
  • Programa Galego de Prevención e Control da TuberculoseDocumentos Técnicos en Saúde Pública: Serie BN°. 35de GaliciaXuntaConsellería de Sanidade e Servicios SociaisDirección Xeral de Saúde PúblicaSantiago2003
  • CruzEFernández-NogueiraEEpidemiology of tuberculosis in Galicia, Spain, 1996–2005Int J Tuberc Lung Dis2007111073107917945063
  • CDCA strategic plan for the elimination of tuberculosis in the United StatesMMWR198938125
  • World Health OrganizationWHO tuberculosis programme: Framework for effective tuberculosis control. WHO/TB/94.1791994 Available from: http://whqlibdoc.who.int/hq/1994/WHO-TB-94.179.pdfAccessed on Mar 10, 2010
  • World Health OrganizationWhat is DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS. WHO/CDC/CPC/TB/99270Geneva, SwitzerlandWorld Health Organization1999
  • Direccion Xeral de Saúde Pública, Consellería de Sanidade, Xunta de GaliciaPrograma galego de prevención e control da tuberculoseDocumentos Técnicos en Saúde Pública. Serie A. N° 13Santiago de Compostela, SpainDirección Xeral de Saúde Pública1995
  • Treatment of tuberculosis for national programmes3rd ed WHO/CDC/TB/2003.313Geneva, SwitzerlandWorld Health Organization2003
  • Pérez del MolinoMLTúnezVCruz-FerroEStudy of Mycobacterium tuberculosis drug resistance in the region of Galicia, SpainInt J Tuberc Lung Dis200591230123516333930
  • BayerDWDirectly observed therapy for tuberculosis: history of an ideaLancet1995345154515487677849
  • MurrayCJLStybloKRoullionATuberculosis in developing countries: burden intervention and costBull Int Union Tuberc Lung Dis1990656242190653
  • AltetNRetraso diagnóstico en tuberculosisEnf Emerg20068163168
  • Surveillance of tuberculosis in Europa-Euro TBReport tuberculosis cases notified in 2006Institut de veille sanitaireSaint-Maurice, France32008 Available from: http://www.erurtb.orgAccessed Mar 10, 2010
  • Caminero LunaJALa erradicación de la tuberculosis: ¿mito o realidad?Enf Emerg20068271281
  • CroftonJChauletPMaherDDirectrices para el tratamiento de la tuberculosis fármacorresistente. WHO/TB/96210 (Rev1)Ginebra, SwitzerlandOrganization Mundial de la Salud1997
  • AzizMAWrightALaszloAEpidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysisLancet20063682142215417174706
  • Anti-tuberculosis drug resistance in the world: fourth global report. WHO/HTM/TB/2008.394Geneva, SwitzerlandWorld Health Organization2008
  • TomiokaHCurrent status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activitiesCurr Pharm Des2006124047407017100611
  • De SouzaMVVasconcelosTRde AlmeidaMVCardosoSHFluoro-quinolones: an important class of antibiotics against tuberculosisCurr Med Chem20061345546316475933
  • CondeMBEfronALoredoCMoxifloxacin in the initial therapy of tuberculosis: a randomized, phase 2 trialLancet20093731183118919345831
  • MwandumbaHCSquireSBFully intermittent dosing with drugs for treating tuberculosis in adultsCochrane Database Syst Rev20014CD00097011687088
  • AlvarezTARodriguesMPViegasCAPrevalence of drug-resistant Mycobacterium tuberculosis in patients under intermittent or daily treatmentJ Bras Pneumol20093555556019618036
  • CoxHSMorrowMDeutschmannPWLong term efficacy of DOTS regimens for tuberculosis: systematic reviewBMJ200833648448718250104
  • JuanGLloretTPerezCDirectly observed treatment for tuberculosis in pharmacies compared with self- administered in SpainInt J Tuberc Dis200610215221
  • AltetMNAlcaldeJCanelaJEstudio del retraso diagnóstico de la tuberculosis pulmonar sintomáticaArch Bronconeumol20033914615212716554

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.